Netherlands· NL-fc870b9ac3bf
Axitinib Sandoz 7 mg, filmomhulde tabletten
A axitinib product containing axitinib, registered in Netherlands by Sandoz B.V.. The same ATC class is registered in 14 of our 19 countries.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
Where it is registered
Axitinib is registered in 14 of 19 countries.
Countries holding a registration under ATC L01EK01 (axitinib), each read from that country’s own register.
- This record: Netherlands, from CBG-MEB (Netherlands)
- 8 of them publish a price we can compare per daily dose
Axitinib · ATC L01EK01
14 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of axitinib costs, country by country.
Normalised to the WHO defined daily dose (10 mg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Axitinib · price per daily dose (10 mg)
USD · FX 28 Sept 2026
- CH Switzerland$89.71
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- AXITINIB
- Manufacturer
- Sandoz B.V.
- Country
- Netherlands (NL)
- ATC code
- L01EK01
- ATC class
- Axitinib
- Defined daily dose
- 10 mg, O
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 29, 2026
Packs & prices · 1
- cbg_meb_id129347
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
205 interactions on record for axitinib.
Graded by severity as the source publishes them — 64 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Axitinib · interactions on record
205 records
- 64 severe
- 117 moderate
- 24 minor
Most severe, free to view
- LonafarnibA16AX20severe
- BosentanC02KX01severe
- ConivaptanC03XA02severe
- MipomersenC10AX11severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Axitinib in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FranceAXITINIB BIOGARAN 7 mg, comprimé pelliculéBIOGARAN
- SwedenAxitinib Sandoz 7 mg Filmdragerad tablettSandoz A/S
- SwitzerlandAxitinib Sandoz
- CzechiaINLYTAPfizer Europe MA EEIG, Bruxelles
- FinlandAxitinib SandozSandoz A/S
- BelgiumAxitinib EG 7 mgEG
- IcelandAxitinib STADASTADA Arzneimittel AG
- NorwayInlytaOrifarm AS
Authorised across Europe · EMA
The same active substance is authorised in 26 EEA countries. Names it is sold under:
- Austria · Axitinib, Axitinib Sandoz
- Belgium · Axitinib Eg, Axitinib Eg (Eurogenerics)
- Bulgaria · Axitinib Sandoz, Акситиниб Тева
- Cyprus · Axitinib Sandoz, Axitinib Stada
- Germany · Axitinib Al, Axitinib Hexal
- Denmark · Axitinib Stada, Axitinib Teva
- Estonia · Axitinib Sandoz, Axitinib Stada
- Spain · Axitinib Stada, Axitinib Teva
- Finland · Axitinib Avansor, Axitinib Sandoz
- France · Axitiinib Eg, Axitinib Biogaran
- United Kingdom (Northern Ireland) · Axitinib Genus Pharmaceuticals, Axitinib Teva Uk
- Greece · Axitinib Faran, Axitinib Sandoz
- Croatia · Aksitinib Alpha-Medical, Aksitinib Teva
- Hungary · Axitinib Onkogen, Axitinib Sandoz
- Iceland · Axitinib Accord, Axitinib Stada
- Italy · Axitinib Eg, Axitinib Sandoz
- Liechtenstein · Axitinib Accord, Inlyta
- Lithuania · Axitinib Sandoz, Axitinib Stada
- Luxembourg · Axitinib Eg, Axitinib Synthon
- Latvia · Axitinib Sandoz, Axitinib Stada
- Malta · Axitinib Synthon
- Norway · Axitinib Accord, Axitinib Sandoz
- Portugal · Axitinib Teva
- Romania · Axitinib Stada
- Sweden · Axitinib Avansor, Axitinib Sandoz
- Slovenia · Aksitinib Sandoz, Aksitinib Teva
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b31dfbce-ad31-4633-90b3-370777cf1c46 GET /v1/drugs/b31dfbce-ad31-4633-90b3-370777cf1c46?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Filmomhulde tablet",
"route": "Oraal gebruik",
"soort": "RVG",
"source": "cbg_meb",
"smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h129347_smpc.pdf",
"strength": null,
"atc_label": "Axitinib",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg129347",
"excipients": [
"CELLULOSE, MICROKRISTALLIJN (E 460(i))",
"CROSCARMELLOSE NATRIUM (E 468)",
"GLYCEROLTRIACETAAT (E 1518)",
"HYPROMELLOSE 2910 (3 - 15 mPa.s) (E 464)",
"IJZEROXIDE ROOD (E 172)",
"LACTOSE 1-WATER",
"MAGNESIUMSTEARAAT (E 470b)",
"TITAANDIOXIDE (E 171)"
],
"substances": [
"AXITINIB"
],
"leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h129347.pdf",
"authorised_at": "2023/03/03",
"procedure_number": "NL/H/5478/004",
"dispensing_status": "Uitsluitend recept",
"registration_number": "129347",
"additional_monitoring": "N"
}See everything about axitinib.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.